Elevance Health
1,621 hedge funds and large institutions have $75.1B invested in Elevance Health in 2026 Q3 according to their latest regulatory filings, with 173 funds opening new positions, 631 increasing their positions, 562 reducing their positions, and 128 closing their positions.
35% more first-time investments, than exits
New positions opened: 173 | Existing positions closed: 128
12% more repeat investments, than reductions
Existing positions increased: 631 | Existing positions reduced: 562
0% more funds holding
Funds holding: 1,618 → 1,621 (+3)
4% less call options, than puts
Call options by funds: $555M | Put options by funds: $579M
3.11% less ownership
Funds ownership: 92.13% → 89.01% (-3.1%)
19% less funds holding in top 10
Funds holding in top 10: 26 → 21 (-5)
26% less capital inflows, than outflows
Capital inflows: $5.3B | Capital outflows: $7.14B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$558M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$431M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$423M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$350M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$333M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$326M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$318M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$304M |
| 4 |
Millennium Management
New York
|
-$289M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$278M |
ELV Hedge Fund Activity: Q3 2026 in Review
1,621 of the 8,208 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q3 2026, worth a combined $75.1B — down 2.7% from $77.2B a quarter earlier.
Buyers outnumbered sellers: 173 funds opened new ELV positions and 128 closed out — a net gain of 45 holders — while 631 added to existing stakes and 562 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $558M. The largest seller was Artisan Partners, cutting an estimated $326M.
- 1,621 institutional investors held Elevance Health (ELV) as of Q3 2026, up from 1,618 in Q2 2026.
- Funds reported $75.1B of Elevance Health stock for Q3 2026, down 2.7% quarter-over-quarter.
- 173 funds opened new Elevance Health positions in Q3 2026 and 128 closed out, a net change of +45 holders.
- The largest Elevance Health buyer in Q3 2026 was AQR Capital Management, an estimated $558M added.
- The largest Elevance Health seller in Q3 2026 was Artisan Partners, an estimated $326M sold.
Based on aggregated 13F filings for Q3 2026.